Cargando…

The FAK inhibitor BI 853520 exerts anti-tumor effects in breast cancer

Focal adhesion kinase (FAK) is a cytoplasmic tyrosine kinase that regulates a plethora of downstream signaling pathways essential for cell migration, proliferation and death, processes that are exploited by cancer cells during malignant progression. These well-established tumorigenic activities, tog...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tiede, Stefanie, Meyer-Schaller, Nathalie, Kalathur, Ravi Kiran Reddy, Ivanek, Robert, Fagiani, Ernesta, Schmassmann, Philip, Stillhard, Patrick, Häfliger, Simon, Kraut, Norbert, Schweifer, Norbert, Waizenegger, Irene C., Bill, Ruben, Christofori, Gerhard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6148276/ https://www.ncbi.nlm.nih.gov/pubmed/30237500 http://dx.doi.org/10.1038/s41389-018-0083-1

Ejemplares similares

Efficacy of the highly selective focal adhesion kinase inhibitor BI 853520 in adenocarcinoma xenograft models is linked to a mesenchymal tumor phenotype
por: Hirt, Ulrich A., et al.
Publicado: (2018)

The FAK inhibitor BI 853520 inhibits spheroid formation and orthotopic tumor growth in malignant pleural mesothelioma
por: Laszlo, Viktoria, et al.
Publicado: (2018)

miR-1199-5p and Zeb1 function in a double-negative feedback loop potentially coordinating EMT and tumour metastasis
por: Diepenbruck, Maren, et al.
Publicado: (2017)

Randomized, Open-Label, Crossover Studies Evaluating the Effect of Food and Liquid Formulation on the Pharmacokinetics of the Novel Focal Adhesion Kinase (FAK) Inhibitor BI 853520
por: Verheijen, Remy B., et al.
Publicado: (2019)

Targeting Metabolic Symbiosis to Overcome Resistance to Anti-angiogenic Therapy
por: Pisarsky, Laura, et al.
Publicado: (2016)

Phase I Study of BI 853520, an Inhibitor of Focal Adhesion Kinase, in Patients with Advanced or Metastatic Nonhematologic Malignancies
por: de Jonge, Maja J. A., et al.
Publicado: (2019)

Phase I Study of the Focal Adhesion Kinase Inhibitor BI 853520 in Japanese and Taiwanese Patients with Advanced or Metastatic Solid Tumors
por: Doi, Toshihiko, et al.
Publicado: (2019)

The novel BET bromodomain inhibitor BI 894999 represses super-enhancer-associated transcription and synergizes with CDK9 inhibition in AML
por: Gerlach, Daniel, et al.
Publicado: (2018)

PyMT-1099, a versatile murine cell model for EMT in breast cancer
por: Saxena, Meera, et al.
Publicado: (2018)

Author Correction: PyMT-1099, a versatile murine cell model for EMT in breast cancer
por: Saxena, Meera, et al.
Publicado: (2020)

Foxf2 plays a dual role during transforming growth factor beta-induced epithelial to mesenchymal transition by promoting apoptosis yet enabling cell junction dissolution and migration
por: Meyer-Schaller, Nathalie, et al.
Publicado: (2018)

Focal adhesion kinase inhibitor BI 853520 inhibits cell proliferation, migration and EMT process through PI3K/AKT/mTOR signaling pathway in ovarian cancer
por: Li, Hong, et al.
Publicado: (2021)

Combination of two novel blocking antibodies, anti-PD-1 antibody ezabenlimab (BI 754091) and anti-LAG-3 antibody BI 754111, leads to increased immune cell responses
por: Zettl, Markus, et al.
Publicado: (2022)

T-cell co-stimulation in combination with targeting FAK drives enhanced anti-tumor immunity
por: Canel, Marta, et al.
Publicado: (2020)

Breast cancer as an example of tumour heterogeneity and tumour cell plasticity during malignant progression
por: Lüönd, Fabiana, et al.
Publicado: (2021)

Phospholipid binding to the FAK catalytic domain impacts function
por: Hall, Jessica E., et al.
Publicado: (2017)

FAK and paxillin: regulators of N-cadherin adhesion and inhibitors of cell migration?
por: Schaller, Michael D.
Publicado: (2004)

Multiple paxillin binding sites regulate FAK function
por: Scheswohl, Danielle M, et al.
Publicado: (2008)

Hierarchy of TGFβ/SMAD, Hippo/YAP/TAZ, and Wnt/β-catenin signaling in melanoma phenotype switching
por: Lüönd, Fabiana, et al.
Publicado: (2021)

RIOK1 kinase activity is required for cell survival irrespective of MTAP status
por: Hörmann, Alexandra, et al.
Publicado: (2018)

BETter together: exploiting BRD4-functions in transcription to inform rational combinations
por: Savarese, Fabio, et al.
Publicado: (2018)

Sociomateriality in Action: Theorizing Change in Sociomaterial Practices of Working from Home
por: Waizenegger, Lena, et al.
Publicado: (2023)

Backtracking on FAK
por: Leslie, Mitch
Publicado: (2008)

FAK monitoring
por: Metzmacher, K D
Publicado: (1974)

Key drivers of biomedical innovation in cancer drug discovery
por: Huber, Margit A, et al.
Publicado: (2015)

The direct effect of Focal Adhesion Kinase (FAK), dominant-negative FAK, FAK-CD and FAK siRNA on gene expression and human MCF-7 breast cancer cell tumorigenesis
por: Golubovskaya, Vita M, et al.
Publicado: (2009)

Funky FAK proliferation
por: Tuma, Rabiya S.
Publicado: (2006)

Deconstructing FAK function
por: Short, Ben
Publicado: (2010)

FAK application software
por: Pearce, P, et al.
Publicado: (1975)

FAK Signaling in Rhabdomyosarcoma
por: Perrone, Clara, et al.
Publicado: (2020)

Py2T Murine Breast Cancer Cells, a Versatile Model of TGFβ-Induced EMT In Vitro and In Vivo
por: Waldmeier, Lorenz, et al.
Publicado: (2012)

Inferring signalling dynamics by integrating interventional with observational data
por: Cardner, Mathias, et al.
Publicado: (2019)

A high-content EMT screen identifies multiple receptor tyrosine kinase inhibitors with activity on TGFβ receptor
por: Lotz-Jenne, Carina, et al.
Publicado: (2016)

FAK-Copy-Gain Is a Predictive Marker for Sensitivity to FAK Inhibition in Breast Cancer
por: Kim, Young-Ho, et al.
Publicado: (2019)

FAK magnet terminating resistors
por: Fiander, D
Publicado: (1974)

FAK hard-wired controls
por: Grier, D
Publicado: (1974)

FAK tank SS71
por: Metzmacher, K D
Publicado: (1975)

Some remarks on the FAK-Spare
por: Bloess, D
Publicado: (1975)

FAK-targeting PROTAC as a chemical tool for the investigation of non-enzymatic FAK function in mice
por: Gao, Hongying, et al.
Publicado: (2020)

The FAM3C locus that encodes interleukin-like EMT inducer (ILEI) is frequently co-amplified in MET-amplified cancers and contributes to invasiveness
por: Schmidt, Ulrike, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rjda04ebeqhlpuajr1vpe0f1sf